Brief Reports
Copyright ©The Author(s) 2005.
World J Gastroenterol. Aug 7, 2005; 11(29): 4579-4582
Published online Aug 7, 2005. doi: 10.3748/wjg.v11.i29.4579
Table 1 Effect of garlicin on CMDI in rats with experimental colitis (mean±SD, n = 10)
GroupCMDI
01234567
Normal control253
Model control1d2d3d3d1d
Garlicin (10.0 mg/kg)2a2a3a2a1a
Garlicin (30.0 mg/kg)5b3b2b
Table 2 Effect of garlicin on expression of bcl-2 and bax and AI in rats with experimental UC (mean±SD, n = 10)
GroupBcl-2BaxAI
Normal control9.8±1.430.1±3.220.8±0.7
Model control41.0±2.5d9.9±0.8d2.3±1.6d
Garlicin (10.0 mg/kg)22.4±0.8a11.2±4.39.8±1.3a
Garlicin (30.0 mg/kg)10.2±2.5b13.1±2.515.3±0.6b